Ignite Creation Date:
2025-12-25 @ 12:17 AM
Ignite Modification Date:
2026-01-02 @ 1:00 PM
Study NCT ID:
NCT06517758
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2024-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-05-27
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-12
First Submit QC Date:
None
Study First Post Date:
2024-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-11
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED